Intracellular localisation of Mycobacterium tuberculosis affects antibiotic efficacy
P. Santucci, D. Greenwood, A. Fearns, K. Chen, H. Jiang, M. G. Gutierrez
Abstract
To be effective, chemotherapy against tuberculosis (TB) must kill the intracellular population of Mycobacterium tuberculosis (Mtb). However, how host cell environments affect antibiotic accumulation and efficacy remains elusive. Pyrazinamide (PZA) is a key antibiotic against TB, yet its behaviour is not fully understood. Here, by using correlative light, electron, and ion microscopy to image PZA at the subcellular level, we investigated how human macrophage environments affect PZA activity. We discovered that PZA accumulates heterogeneously between individual bacteria in multiple host cell environments. Crucially, Mtb phagosomal localisation and acidification increase PZA accumulation and efficacy. By imaging two antibiotics commonly used in combined TB therapy, we showed that bedaquiline (BDQ) significantly enhances PZA accumulation by a host cell mediated mechanism. Thus, intracellular localisation and specific microenvironments affect PZA accumulation and efficacy; explaining the potent in vivo efficacy compared to its modest in vitro activity and the critical contribution to TB combination chemotherapy.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Visualizing pyrazinamide action by live single cell imaging of phagosome acidification and Mycobacterium tuberculosis pH homeostasis
P. Santucci, B. Aylan, … M. G. Gutierrez·bioRxiv·Dec 20, 2021
- Essential Role of MHC II in the Antitubercular Efficacy of Pyrazinamide
Elise A. Lamont, Shannon Lynn Kordus, … Anthony D. Baughn·Antimicrobial Agents and ChemotherapyPeer-reviewed·Dec 19, 2025
- Reliable detection of pyrazinamide antitubercular activity in vitro.
A. Gouzy, C. F. Healy, … S. Ehrt·bioRxiv·May 22, 2022
- Oxidative stress drives potent bactericidal activity of pyrazinamide against Mycobacterium tuberculosis
Nicholas Allen Dillon, Elise A. Lamont, … Anthony D. Baughn·bioRxiv·Dec 17, 2024
- Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification
Janïs Laudouze, Tatyana I. Rokitskaya, … Pierre Santucci·bioRxiv·Sep 26, 2025
- Pyrazinamide action is driven by the cell envelope stress response in Mycobacterium tuberculosis
J. M. Thiede, N. Dillon, … A. D. Baughn·bioRxiv·Feb 17, 2021